Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Neutron brachytherapy in the modern era: Indications and evidence (2023) |
Auteurs : | P. Loap ; A. Barcellini ; L. de Marzi ; E. Orlandi ; Y. Kirova |
Type de document : | Article |
Dans : | Cancer/Radiothérapie (Vol. 27, n° 2, Avril 2023) |
Article en page(s) : | p. 170-177 |
Note générale : | https://doi.org/10.1016/j.canrad.2022.08.010 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Curiethérapie |
Mots-clés: | Curiethérapie par neutrons ; Hadronthérapie |
Résumé : | Hadrontherapy is a form of radiation therapy (RT) that relies on heavy particles, such as proton, heavy ions, or neutrons, to enhance anti-tumoral efficacy based on their specific dosimetric and radio-biological properties. Neutrons are characterized by specific radiobiological properties that might deserve greater consideration, including the high linear energy transfer and the low oxygen enhancement ratio. Neutron brachytherapy, relying on interstitial or intracavitary neutron sources, has been developed since the 1950s using Californium-252 (252Cf) as a mixed emitter of fission fast neutrons and γ-photos. However, the place of NBT in the era of modern radiation therapy is yet to be precisely defined. In this systematic review, we aim to provide an up-to-date analysis of current experience and clinical evidence of NBT in the XXI th century, by answering the following clinical questions: How is NBT currently delivered? What are the current efficacy data and tolerance profiles of NBT? |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S1278321823000094 |